I didn't believe that AI-powered slide analysis could beat NGS to ID genomic biomarkers. But if it works, it could make precision oncology accessible and equitable. I spoke w/ UCSD Health Moores Cancer Center COE spinoff io9 about their Journal of Clinical Oncology study. insideprecisionmedicine.com/topics/oncolog… via Inside Precision Medicine

6-7August: What solution is Schrödinger working on to predict the toxicity risk of new drugs early in their development? Hear from CEO Ramy Farid, PhD, & Karen Akinsanya, PhD, President of R&D, Therapeutics in my latest for Genetic Engineering & Biotechnology News: genengnews.com/topics/artific…

Alex Philippidis Schrödinger Genetic Engineering & Biotechnology News Schrodinger Inc.'s innovation in predicting early toxicity risks is crucial for public healthcare. Excited to see how this improves community health standards!

8August: Why does Recursion reason it will benefit from its planned acquisition of Exscientia, announced today? Read details on the deal in my latest for Genetic Engineering & Biotechnology News: genengnews.com/topics/artific…

While we still see BD opportunities for RXRX, the stock remains a show-me story and we remain on the sidelines as we await readouts in key clinical programs for clearer insight on the differentiation of its platform —Mani Foroohar, Leerink Alex Philippidis genengnews.com/topics/artific…

SundayBest (Prayer To the Most Holy Theotokos): You who are the compassionately loving Mother of the merciful God, have mercy on me and give my heart compunction and contrition, humility in my thoughts, and release from my captive thoughts.

12August: How much in revenues did blockbuster GLP-1 #obesity & #diabetes drugs generate for Eli Lilly and Company and Novo Nordisk so far this year? My latest StockWatch for Genetic Engineering & Biotechnology News: genengnews.com/topics/drug-di…

Alex Philippidis Eli Lilly and Company Novo Nordisk Genetic Engineering & Biotechnology News I'm more concerned about the rapid approval and deployment of these drugs without fully transparent clinical data.

SundayBest (Prayer of St. Basil the Great): For You are the bread of life, the well-spring of holiness, and the giver of all that is good, and to You we ascribe the glory, with the Father and the Holy Spirit, now and forever and to the ages of ages. Amen.

20-21August: What did analysts find positive, and where were they more cautious, about Illumina's new company growth strategy? Read about $ILMN plus updates on $BLUE and $RVNC in my latest StockWatch for Genetic Engineering & Biotechnology News: genengnews.com/topics/omics/s…

SundayBest (Prayer of the Trisagion Hymn): Grant that we may worship You in holiness all the days of our lives, through the intercessions of the holy Theotokos and of all the saints who have pleased You throughout the ages.

27August: Inviting you to "The State of Biotech," Genetic Engineering & Biotechnology News’s FREE flagship virtual event on Sept. 11. Our program features 3 keynoters--David Altschuler of Vertex Pharmaceuticals; Sonia Vallabh of Broad Institute; John F Crowley of I Am Biotech--and much more! webinars.liebertpub.com/e/The-State-of…

27August: Which are the Top 10 Contract Development and Manufacturing Organizations as ranked by revenue? My latest A-List for Genetic Engineering & Biotechnology News: genengnews.com/topics/bioproc…

29August: Fifteen years, can you believe it?! #MyXAnniversary

8 Contract Development and Manufacturing Companies to Watch Surprised at the companies in Alex Philippidis's Top 10 Contract Development and Manufacturing Organizations 2024? In addition, he brings you his companies to watch list. Read now: hubs.li/Q02N0ZdH0

SundayBest (Apolytikion of Beginning of the Indiction): Creator of the universe, setting times and seasons by Your sole authority, bless the cycle of the year of Your grace, O Lord, guarding our rulers and Your nation in peace, at the intercession of the Theotokos, and save us.

3September: Pleased as punch to announce I'll be delivering my now-annual "Top 10 U.S. Biopharma Clusters" presentation at the BioHealth Capital Region (BioHealth Cap Region)'s upcoming 2024 Forum set for September 17-18 in Rockville, MD. Look forward to meeting everyone at the event!

3September: Why were investors less than impressed with the data Neurocrine Biosciences generated from a Phase II trial of its schizophrenia candidate NBI-1117568? Read about $NBIX plus updates on $ENSC, $IVVD, and $SNOA in my latest StockWatch for Genetic Engineering & Biotechnology News: genengnews.com/topics/drug-di…

4September: How does Eli Lilly and Company plan to apply HAYA Therapeutics's long noncoding RNA platform to make new drugs to treat #obesity and metabolic disorders? Read what HAYA CEO Samir Ounzain, PhD told me in my latest for Genetic Engineering & Biotechnology News: genengnews.com/topics/drug-di…